8-K ·Filed Apr 13, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor insider exercise behavior and future dilution; assess whether retention efforts correlate with future R&D or funding milestones.
Final — all horizons settled through T+60d
VTGN ▼ -58.47% at T+60d
NEUTRAL call ✗ call lost -58.47% · α vs SPY -66.99% · entry $0.6000 → $0.2492
T+1d
+1.67%
call +1.67% · α +0.89%
$0.6100
settled 6mo ago
T+5d
+1.67%
call +1.67% · α +0.27%
$0.6100
settled 6mo ago
T+20d
+11.67%
call +11.67% · α +5.37%
$0.6700
settled 5mo ago
T+60d
-58.47%
call -58.47% · α -66.99%
$0.2492
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Vistagen Therapeutics granted stock options to purchase 75,000 shares each to its CEO and other executive officers as retention awards. The options vest over two years and are intended to incentivize key leadership.
Key Facts
- Retention stock options granted to CEO Shawn K. Singh and four other executive officers.
- Each executive received options to purchase 75,000 shares of common stock.
- Options have an exercise price of $0.5358 per share and vest 25% every six months over two years.
- Awards were approved by the Compensation Committee on April 7, 2026, under the 2019 Omnibus Equity Incentive Plan.
Financial Impact
Dilutive impact of up to 375,000 new shares if all options are exercised; nominal expense recognition over two years based on fair value.
equity dilutionstock-based compensation
Risk Factors
- Potential shareholder dilution upon option exercise.
- Limited cash runway implications if future financing is needed to support ongoing operations.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-024943 |
| Document: 0001628280-26-024943-index-headers.html | 0001628280-26-024943 |
| Document: 0001628280-26-024943-index.html | 0001628280-26-024943 |
| Document: 0001628280-26-024943.txt | 0001628280-26-024943 |
12 reports for VTGN
67% Hit rate best @ T+5▲ +20.40%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $0.2676 $0.2432 | ▲ +9.12% | ▲ +7.13% | $0.2847 (−6.39%) |
Aug 14, 2026 7w ago | Press Release | $0.2676 $0.2432 | ▼ −9.12% | ▼ −7.13% | $0.2847 (+6.39%) |
Jul 31, 2026 9w ago | 8-K | $0.2410 $0.2529 | ▲ +4.94% | ▲ +1.95% | $0.2847 (+18.13%) |
Jun 30, 2026 13w ago | 8-K | $0.2260 $0.2302 | ▼ −1.86% | ▼ −2.89% | $0.2847 (−25.97%) |
Jun 17, 2026 15w ago | 8-K | $0.6702 $0.2400 | ▼ −64.19% | ▼ −64.72% | $0.2847 (−57.52%) |
Jun 15, 2026 15w ago | 8-K | $0.6900 $0.2461 | ▼ −64.33% | ▼ −64.53% | $0.2847 (−58.74%) |
Jun 11, 2026 16w ago | Institutional Cluster | $0.5731 $0.2492 | ▼ −56.52% | ▼ −58.41% | $0.2847 (−50.32%) |
Jun 9, 2026 16w ago | 8-K | $0.5351 $0.2492 | ▼ −53.43% | ▼ −57.05% | $0.2847 (−46.79%) |
May 19, 2026 19w ago | 8-K | $0.6400 $0.6702 | ▲ +4.72% | ▲ +3.98% | $0.2847 (−55.52%) |
May 12, 2026 20w ago | 8-K | $0.6200 $0.5400 | ▼ −12.90% | ▼ −11.18% | $0.2847 (−54.08%) |
Showing 10 of 12
US Market Status
Market Open — Closes in 2h 18m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access